|
|
Volumn 4, Issue 6, 1999, Pages 659-663
|
|
A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ALPHA INTERFERON;
BCR ABL PROTEIN;
BIOLOGICAL RESPONSE MODIFIER;
HYDROXYUREA;
TUMOR MARKER;
ADOLESCENT;
ADULT;
AGED;
ANEUPLOIDY;
ARTICLE;
BONE MARROW;
CANCER STEM CELL;
CHEMISTRY;
COMPARATIVE STUDY;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENETICS;
HUMAN;
KARYOTYPING;
LIFE TABLE;
MALE;
MIDDLE AGED;
MORTALITY;
MYELOID LEUKEMIA;
PATHOLOGY;
PHILADELPHIA 1 CHROMOSOME;
SURVIVAL RATE;
ULTRASTRUCTURE;
ADOLESCENT;
ADULT;
AGED;
ANEUPLOIDY;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BIOLOGICAL RESPONSE MODIFIERS;
BONE MARROW;
FEMALE;
FUSION PROTEINS, BCR-ABL;
HUMANS;
HYDROXYUREA;
IN SITU HYBRIDIZATION, FLUORESCENCE;
INTERFERON-ALPHA;
KARYOTYPING;
LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE;
LIFE TABLES;
MALE;
MIDDLE AGED;
PHILADELPHIA CHROMOSOME;
SURVIVAL RATE;
TUMOR MARKERS, BIOLOGICAL;
TUMOR STEM CELLS;
|
|
EID: 0033258250
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.4.6.659 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
